Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27821648 | 0.88 | FAAH (0.80) | FAAH | |
| SCHEMBL12611670 | 0.87 | FAAH (0.78) | FAAH | |
| SCHEMBL23356538 | 0.87 | FAAH (0.78) | FAAH | |
| SCHEMBL23356537 | 0.87 | FAAH (0.78) | FAAH | |
| SCHEMBL3692928 | 0.86 | FAAH (0.85) | FAAH | |
| SCHEMBL192218 | 0.86 | FAAH (0.85) | FAAH | |
| SCHEMBL232667 | 0.84 | FAAH (0.77) | FAAH | |
| SCHEMBL18673205 | 0.84 | FAAH (0.74) | FAAH | |
| SCHEMBL1978094 | 0.84 | FAAH (1.00) | FAAH | |
| SCHEMBL194610 | 0.83 | FAAH (0.78) | FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130045948-A1 | AZOCYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-02-21 | — | — | US | disclosed |
| EP-2509978-A1 | AZOCYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | E.I. Du Pont De Nemours And Company (US) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011072207-A1 | AZOCYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045948-A1 | AZOCYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | FAAH, FAAH2, NCEH1 | FAAH 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.